Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast report published by Renub Research. According to this report, in the Baltic Countries, Lithuania is having the highest seasonal influenza vaccine market share followed by Latvia and Estonia. In terms of children vaccination, Lithuania & Latvia hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 95 percent market share by 2022.
This report provides a complete analysis of 3 Baltic Countries (Lithuania, Estonia, Latvia) Seasonal Influenza Vaccine Market (Child & Adult), Number of Vaccinated Population (Child & Adult) and Forecast till 2022. All the 3 countries in the report have been studied from 2 viewpoints.
2. Seasonal Influenza Vaccinated Population in Baltic Countries (2011 – 2022) - Seasonal Influenza Vaccinated Population & Forecast - Children Seasonal Influenza Vaccinated Population & Forecast - Adult Seasonal Influenza Vaccinated Population & Forecast
Countries studied in the report are as follows
- Lithuania - Estonia - Latvia
Our reports have been used by over 10K customers, including:
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
With a population of more than 1 billion, China is the worldâ€™s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro...
The intravascular temperature management market is expected to register a CAGR of 3.6% during the next five years. The intravascular temperature management market is expected to register a CAGR of 3.6% to reach USD 272.3 million by 2022 from USD 228.4 million in 2017. Market growth can be attributed the large number of...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.